NTS and prostate cancer: Neurotensin (NT) and neurotensin-like peptide neuromedin N (NMN) are derived from the same polypeptide precursor [13], neurotensin receptors (NTRS1, NTRS2 and NTRS3) being overexpressed by lung, breast cancer, colon or prostate cancer.